Equitec Specialists’s DexCom DXCM Stock Holding History

Equitec Specialists’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,000	Closed	-$109K	–	129
2019 Q4	$109K	Buy	+2,000	New	+$94.9K	0.03%	90

Other funds holding DXCM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Equitec Specialists's DXCM Position: Q1 2020 in Review

Equitec Specialists sold out of DexCom (DXCM) in Q1 2020, closing a stake of 2,000 shares — an estimated $109K sold.

Equitec Specialists first reported a position in DXCM in Q4 2019 and held it in 1 quarter. The position peaked at $109K in Q4 2019. 593 funds tracked by Wall St. Rank hold DXCM as of Q1 2020.

Equitec Specialists reported no remaining DexCom position as of Q1 2020 after selling out during the quarter.
Equitec Specialists sold 2,000 DexCom shares in Q1 2020, an estimated $109K.
Equitec Specialists first reported a position in DexCom in Q4 2019 and held it in 1 quarter.
Equitec Specialists's DexCom position peaked at $109K in Q4 2019.
593 funds tracked by Wall St. Rank held DexCom as of Q1 2020.

Based on Equitec Specialists's 13F filing for Q1 2020, filed 23 Apr 2020.